|
|
41
|
|
|
B151A
|
|
|
XARELTO 2.5MG TAB (BSP) RIVAROXABAN (C)
|
|
|
RIVAROXABAN
|
|
|
XARELTO
|
|
|
56'S
|
|
|
C
|
|
|
169.62
|
|
|
3.029
|
|
|
2.5MG
|
|
|
TAB
|
|
|
60
|
|
|
BOX
|
|
|
BSP
|
|
|
BAYER SCHERING PHARMA AG.
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
N
|
|
|
20120412
|
|
|
DIRECT THROMBIN INHIBITORS
|
|
|
|
|
|
ORAL
|
|
|
6
|
|
|
DIRECT THROMBIN INHIBITORS
|
|
|
|